PERSPECTA

News from every angle

← Back to headlines

Cytokinetics Presents Late-Breaking Data on Heart Failure Drugs at ESC Congress 2026

Cytokinetics announced additional clinical trial results for its ACACIA-HCM and MAPLE-HCM programs during a late-breaking session at the European Society of Cardiology Congress, advancing treatments for hypertrophic cardiomyopathy.

29 Aug, 14:30 — 29 Aug, 14:30
PostShare

Sources

Showing 1 of 1 sources
taiwan-newsMostly Factual23h ago

Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 - Taiwan News

Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026  Taiwan News

Read full article →

Related Stories

Austria Reports Record Heat-Related Deaths in Summer Months

2h ago

Nigeria Urges Early Cancer Detection to Improve Treatment Outcomes

3h ago

Rabies Detected in Baby Goats at North Carolina Mobile Petting Zoo

10h ago

48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room

1d ago